DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Sands BE, Peyrin-Biroulet L, Loftus Jr. EV. et al
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
N Engl J Med 2019;
381: 1215-1226
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.